The General Pharmaceutical Council (GPhC) has proposed publishing “diversity data” related to fitness-to-practise cases as part of its equality, diversity and inclusion strategy. The GPhC’s five-year strategy (https://www.pharmacyregulation.org/sites/default/files/document/council_meeting_paper s_11_march_2021.pdf) , which will be discussed at its council meeting on 11 March 2021 ahead of a public consultation, said it aims to “make regulatory decisions which are demonstrably fair, lawful, and so free from discrimination and bias” .
展开▼
